$EXEL breakout gap candle Pr. $4.09 http://pat
Post# of 73
Posted On: 07/15/2014 7:31:18 AM
$EXEL breakout gap candle Pr. $4.09
Website
Exelixis Announces Positive Top-Line Results
for Phase 3 Pivotal Trial of Cobimetinib in Combination With
Vemurafenib in Patients With BRAF V600 Mutation-Positive
Advanced Melanoma
2014-07-14 01:00 ET - News Release
O/S shares 194,694,949
10-Q 5/1/14
Website
Exelixis Announces Positive Top-Line Results
for Phase 3 Pivotal Trial of Cobimetinib in Combination With
Vemurafenib in Patients With BRAF V600 Mutation-Positive
Advanced Melanoma
2014-07-14 01:00 ET - News Release
O/S shares 194,694,949
10-Q 5/1/14
(0)
(0)Exelixis Inc. (EXEL) Stock Research Links
Scroll down for more posts ▼